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Background: Chronic obstructive pulmonary disease (COPD) is known to greatly affect ventilation (V) and perfusion
(Q) of the lung through pathologies such as inflammation and emphysema. However, there is little direct evidence
regarding how these pathologies contribute to the V/Q mismatch observed in COPD and models thereof. Also,
little is known regarding how smoking cessation affects V/Q relationships after inflammation and airspace
enlargement have become established. To this end, we have quantified V/Q on a per-voxel basis using single
photon emission computed tomography (SPECT) in mouse models of COPD and lung obstruction.
Methods: Three distinct murine models were used to investigate the impact of different pathologies on V/Q, as
measured by SPECT. Lipopolysaccharide (LPS) was used to produce neutrophilic inflammation, porcine pancreatic
elastase (PPE) was used to produce emphysema, and long-term cigarette smoke (CS) exposure and cessation were
used to investigate the combination of these pathologies.
Results: CS exposure resulted in an increase in mononuclear cells and neutrophils, an increase in airspace
enlargement, and an increase in V/Q mismatching. The inflammation produced by LPS was more robust and
predominantly neutrophilic, compared to that of cigarette smoke; nevertheless, inflammation alone caused V/Q
mismatching similar to that seen with long-term CS exposure. The emphysematous lesions caused by PPE
administration were also capable of causing V/Q mismatch in the absence of inflammation. Following CS cessation,
inflammatory cell levels returned to those of controls and, similarly, V/Q measures returned to normal despite
evidence of persistent mild airspace enlargement.
Conclusions: Both robust inflammation and extensive airspace enlargement, on their own, were capable of
producing V/Q mismatch. As CS cessation resulted in a return of V/Q mismatching and inflammatory cell counts to
control levels, lung inflammation is likely a major contributor to V/Q mismatch observed in the cigarette smoke
exposure model as well as in COPD patients. This return of V/Q mismatching to control values also took place in
the presence of mild airspace enlargement, indicating that emphysematous lesions must be of a larger volume
before affecting the lung significantly. Early smoking cessation is therefore critical before emphysema has an
irreversible impact on gas exchange.
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Ventilation (V) and perfusion (Q) are fundamental physio-
logical processes within the lung contributing to gas ex-
change, and the relationship between these processes is
dysfunctional in patients with chronic obstructive pul-
monary disease (COPD) [1]. Cigarette smoke (CS) is a
primary risk factor for the disease, prolonged exposure
to which can lead to airway inflammation, airspace en-
largement, and several other pathologies [2], ultimately
resulting in irreversible airflow limitation [3,4]. Cessation
of cigarette smoking is capable of slowing the progression
of COPD but years of cessation are often necessary before
improvements to airflow limitation, inflammatory state,
infection risk, and cardiovascular comorbidities are seen
[5,6]. To better understand the benefits and limitations of
smoking cessation, the impact on V/Q requires investi-
gation in the context of the pathologies associated with
cigarette smoke exposure.
V/Q relationships in the lung can be measured by sev-
eral non-invasive methods but these techniques are not
commonly used in clinical practice, aside from the diag-
nosis of pulmonary embolism; quantification of results,
even in clinical research, is rare. Rodríguez-Roisin et al.
[7] made use of the multiple inert gas elimination tech-
nique (MIGET) to quantitatively demonstrate that V/Q
is a sensitive measure of the earliest stages of COPD. A
more widely available methodology for V/Q can be per-
formed in nuclear medicine departments utilising single
photon emission computed tomography (SPECT) to pro-
vide three-dimensional maps of ventilation and perfusion
[8,9]. Jogi et al. [10] have shown the ability of this technique
to identify early disease and stage disease severity in COPD
patients. Further, Suga et al. [11] have quantified the impact
of emphysema on V/Q in the lungs of COPD patients.
Modelling aspects of COPD in mice provides the means
by which to investigate the individual pathologies that
make up this heterogeneous disease [12]. Using a metho-
dology adapted from clinical V/Q SPECT to a murine
model, our laboratory has confirmed the utility of this
technique in measuring changes in V/Q with age [13] and
in the context of prolonged cigarette smoke exposure [14].
Understanding the mechanisms behind V/Q mismatch
in COPD-associated pathologies is an important step in
furthering the ability to diagnose and treat this widespread
and burdensome disease. In the current study, the impact
of smoking cessation on V/Q mismatching has been inves-
tigated. In addition, the contributions of inflammation and
airspace enlargement have been examined, by employing
simple models for these pathologies, to provide insight
into the dysfunction associated with cigarette smoke ex-
posure. We have sought to explore the V/Q relationships
associated with cigarette smoke exposure using these
models alongside cellular and structural assessments,
using both traditional and non-invasive methods.Materials and methods
Animals
Specific pathogen-free 10–12 week old female BALB/c
mice were purchased from Charles River Laboratories
(Senneville, QC, Canada). The studies were approved by
McMaster University’s Animal Research Ethics Board in
accordance with the Canadian Council on Animal Care
guidelines.Cigarette smoke exposure protocol
Mice were exposed to cigarette smoke 5 days/week using
a SIU48 whole body exposure system (Promech Lab,
Vintrie, Sweden). Details of the exposure protocol have
been reported previously [15]. Control animals were ex-
posed to room air only. Following 24 weeks of smoke
exposure, mice were divided into two groups, continued
smoke exposure and smoke cessation, and studied for
16 weeks. Controls continued to receive room air.Lipopolysaccharide exposure protocol
To model neutrophilic lung inflammation, mice intra-
nasally received either 10.5 μg of LPS (Sigma-Aldrich,
Oakville, ON, Canada) in 35 μL of sterile phosphate-
buffered saline (PBS) or PBS only. Animals were imaged
24 hours post LPS exposure and sacrificed immediately
after imaging.Porcine pancreatic elastase exposure protocol
To model emphysema, mice intranasally received 4 units
of PPE (EPC Inc., Owensville, MO, USA) in 30 μL of
sterile PBS or PBS only. After exposure mice were left
for a period of 45 days prior to acquisition of data.Imaging protocol and per-voxel image analysis
Imaging was performed as previously described [13] with
minor modifications. SPECT scans were acquired on an
X-SPECT system (Gamma Medica, Northridge, CA,
USA). Technegas™ and 99mTc-macroaggregated albumin
were used to provide the distributions of V and Q, re-
spectively. CT images were acquired for both SPECT
scans, also on the X-SPECT. SPECT and CT images
were reconstructed, fused, and co-registered as previ-
ously described [13]. A ‘Lung’ region of interest (ROI)
was produced for the ventilation CT images using Amira
5.1 software (Visage Imaging, Andover, MA, USA) and
used during co-registration and analysis. V/Q ratios were
calculated using normalised V and Q frequencies. To as-
sess emphysema in CT images, volumes of low attenu-
ation (VLA) were calculated by summing the percentage
of lung volume less than -400HU. Additional details re-
garding this threshold and other specifics of the methods
used are provided in the Additional file 1.
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Mice were sacrificed at the experimental endpoints indi-
cated in the results. Bronchoalveolar lavage (BAL) was col-
lected and measures of airspace enlargement were made
(Pneumometrics software V.1, Hamilton, Ontario, Canada)
from haemotoxylin and eosin (H&E) stained lung histology
sections as described previously [14]. BAL cell counts and
the histological data for animals at 24 weeks CS have been
reported previously [14]. Additional detail regarding lung
fixation, histological assessment, and BAL quantification is
provided in the Additional file 1.
Data analysis
Data were expressed as the mean ± SEM. Statistical sig-
nificance was determined by an unpaired, two-tailed t-test
in Prism (Graphpad Software Inc, La Jolla, CA, USA)
when comparing age-matched experimental groups. For
cessation-related data, a one-way ANOVA with Tukey
post-hoc test was performed. p < 0.05 was considered
statistically significant for all statistical tests. The num-
ber of mice studied is described in Table one, found in
the Additional file 1.
Results
Cigarette smoke exposure caused V/Q mismatch,
inflammation, and airspace enlargement
Mice were exposed to CS for 24 weeks to establish the de-
gree of V/Q mismatching and the lung conditions in which
mismatching takes place. Exposure to cigarette smoke for a
period of 24 weeks elicited significant V/Q mismatching
but no density changes were observed in CT images com-
pared to controls (Figure 1A). Quantification of log(V/Q)
curves (Figure 1B) yielded a significant decrease in the
mean and a significant increase in the standard deviation ofFigure 1 Impact of 24 weeks smoke exposure on lung function. A Rep
and cigarette smoke exposed (bottom) animals after 24 weeks. Green repre
represent increasing values of low and high V/Q, respectively. B Log(V/Q) d
D Average log(V/Q) standard deviation values. *p < 0.05, **p < 0.01 by two-the data (Figure 1C&D). Analysis of BAL fluid demon-
strated that 24 weeks of smoke exposure caused robust in-
flammation, with a total cell count of 3.3 ± 0.5 ×106
compared to 0.8 ± 0.1 ×106 for controls. Similarly, increases
were observed for both mononuclear cells and neutrophils
(Figure 2A). A shift towards greater airspace size was
observed histologically in the distribution of airspace
area (Figure 2B) and statistically confirmed by quantifi-
cation of the airspace area beyond the control 75th per-
centile (data not shown). In addition, a decrease of the
number of airspaces per unit area (Figure 2C) was seen.
Thus, CS exposure caused V/Q mismatch in the context
of both inflammation and a small but significant degree
of airspace enlargement.
Inflammation alone caused V/Q mismatch
The effect of inflammation on V/Q mismatch was investi-
gated by exposing mice to LPS. LPS exposure produced a
total cell count of 5.3 ± 0.4 ×106 compared to 0.7 ± 0.1×106
for control animals; this increase was almost entirely neu-
trophilic (Figure 3). The increased inflammation asso-
ciated with LPS was also apparent in CT images, as
depicted by peribronchial increases in density (Figure 4A).
The log(V/Q) distribution demonstrated that this inflam-
mation was capable of altering lung function (Figure 4B)
and significant changes were observed in both the mean
and standard deviation of these data (Figure 4C and D).
Thus, neutrophilic inflammation alone was capable of
causing V/Q mismatch.
Airspace enlargement alone caused V/Q mismatch
The role of airspace enlargement in V/Q mismatching
was next investigated as a major pathology associated
with COPD. To produce airspace enlargement greaterresentative axial CT (left) and log(V/Q) (right) images for control (top)
sents matched V/Q while colours progressing towards purple and red
istributions for animals at 24 weeks. C Average mean log(V/Q) values.
tailed t-test compared to age-matched controls.
Figure 2 Inflammation and airspace enlargement after
24 weeks smoke exposure. A BAL total cells, mononuclear cells,
and neutrophils at 24 weeks. B Average airspace area distributions
by logarithmic bins of airspace size for 24 weeks, describing whole
slice histology. C Average airspaces per unit area. D Average area to
perimeter ratio produced from analysis of whole slice histology at
24. **p < 0.01 by two-tailed t-test compared to
age-matched controls.
Figure 3 BAL cell counts for LPS exposure. Total cells and the
associated number of mononuclear cells and neutrophils are shown.
***p < 0.001 by two-tailed t-test compared to age-matched controls.
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mice were exposed to PPE. Emphysema-like lesions were
readily apparent in the CT images (Figure 5A). While the
control group was described by a bimodal distribution
representing air- and tissue-filled regions within the lung
segmentation, the PPE group showed a large leftward shift
towards lower density values, indicating a greater extent of
air within the lung (Figure 5B). The lung ROI volume ana-
lysed was significantly greater in PPE-exposed animals than
in controls (Figure 5C). When the percentage of volume
below -400HU was calculated, a threshold describing em-
physematous lesions, a significant increase was found in
PPE animals (Figure 5D) with 21.9 ± 2.4% of the lung
volume below -400HU compared to 0.6 ± 0.1% in controls.
Log(V/Q) measurements were affected by the altered
lung structure produced by PPE exposure, though no
consistent pattern was observed relating emphysema-
tous lesions to mismatched V/Q (Figure 6A). A broad-
ening of the log(V/Q) distribution was seen (Figure 6B)
and was further described by a significant decrease in
the mean and an increase in the standard deviation
(Figure 6C and D). No difference was observed in BAL
inflammatory levels between control and PPE exposed
mice at the experimental endpoint (data not shown).
Therefore, emphysematous lesions were capable of pro-
ducing V/Q mismatch, which appeared to be distributed
throughout the lung.
Cigarette smoke cessation resolved V/Q mismatch
Cessation of cigarette smoke exposure was next examined
to determine the relative roles of inflammation and air-
space enlargement to the V/Q mismatching observed after
24 weeks of exposure. Following 16 weeks of cessation,
significant decreases were observed in the BAL total cell
count, as well as within the mononuclear and neutrophil
compartments, bringing these levels back to those ob-
served in controls (Figure 7A). However, the lungs of
smoking cessation animals still showed evidence of
bronchial associated lymphoid tissue (Figure 7B); these
immune structures were present after 24 weeks of smoke
exposure and did not resolve over this period of cessation.
Histological analysis of airspace enlargement demon-
strated that continuing smoke and cessation groups had
similar airspace area distribution profiles (Figure 7C). The
percentage of area above the control 75th percentile was
significantly increased in both of these groups compared
to controls (data not shown). Similarly, the decrease in the
number of airspaces per unit area (Figure 7D), and an
increase in the area to perimeter ratio (Figure 7E), con-
firmed that the airspace enlargement seen at 24 weeks
was still apparent after 16 weeks of cessation.
There was no discernible difference in log(V/Q) distri-
butions between control animals and those that stopped
smoking after 24 weeks of cigarette smoke exposure while
Figure 4 Functional impact of LPS exposure. A Representative axial CT (left) and log(V/Q) (right) images for control (top) and LPS exposed
animals (bottom). Green represents matched V/Q while colours progressing towards purple and red represent increasing values of low and high
V/Q, respectively. B Log(V/Q) distributions. C Average mean log(V/Q) values. D Average log(V/Q) standard deviation. *p < 0.05, **p < 0.01 by
two-tailed t-test compared to age-matched controls.
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distribution (Figure 8A&B). With smoking cessation a sig-
nificant increase of the mean log(V/Q) value, from −0.08 ±
0.01 after 24 weeks smoke exposure to −0.03 ± 0.01 after
16 weeks of smoking cessation, and a significant decrease
of the standard deviation of this data, from 0.38 ± 0.02
to 0.33 ± 0.02 after cessation, was observed. Thus, cessa-
tion for 16 weeks returned V/Q mismatching back to
control values.
Discussion
Ventilation and perfusion of the lung can be compro-
mised in COPD, and the capability of matching these
processes dysregulated. The objective of the currentFigure 5 Density-based analysis of PPE imaging data. A Representative
controls. B Average Hounsfield unit (HU) density distributions for control a
(ROI). D Quantification of percentage of volume with density values less th
signifying severe airspace enlargement. **p < 0.01, ***p < 0.001 by two-taistudy was to investigate the V/Q perturbations associ-
ated with two of the major pathologies associated with
COPD using mouse models of neutrophilic inflamma-
tion and emphysema. Further, the impact of smoking
cessation was described and evidence gathered regarding
the relative roles of inflammation and airspace enlarge-
ment in V/Q mismatching.
The mouse models employed in the studies presented
were relatively simple in nature to allow for effective inter-
pretation of results. These models, utilising LPS, PPE, and
cigarette smoke, are all well-established and the impact of
these exposures on resistance to airflow, the immune sys-
tem, and other aspects of the lung have been reviewed
previously [12]. Investigation of V/Q relationships in theseaxial, sagittal, and coronal CT slices from PPE-exposed and age-matched
nd PPE-exposed groups. C Volume of the lung region of interest
an -400HU, A.K.A. percentage volume of low attenuation (%VLA),
led t-test compared to age-matched controls.
Figure 6 PPE-induced damage and V/Q mismatch. A Representative axial CT (left) and log(V/Q) (right) images for control (top) and PPE
exposed (bottom) animals. Green represents matched V/Q while colours progressing towards purple and red represent increasing values of low
and high V/Q, respectively. B Log(V/Q) distributions for animals 45 days after PPE exposure. C Average mean log(V/Q) values. D Average log(V/Q)
standard deviation values following PPE exposure. *p < 0.05, **p < 0.01, by two-tailed t-test compared to age-matched controls.
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pathological disruption on the potential for gas exchange.
The LPS and PPE models, causing inflammation and air-
space enlargement, respectively, were used as examples of
severe pathology, so the V/Q mismatching observed was
not surprising. It is important to note that the extent and
distribution of pathology associated with these adminis-
tered reagents does not necessarily reflect the pathologies
found in COPD, but demonstrate that each causes V/Q
mismatching. Cigarette smoke, on the other hand, caused
less pronounced inflammation and only subtle airspace
enlargement but nevertheless caused V/Q mismatching
similar to that observed in the other models employed.
A seminal article by Wright and Sun [16] investigated
long-term smoking cessation in guinea pigs and found that
airspace enlargement persists in ex-smokers while pulmon-
ary function increases over their smoking counterparts.
Similarly, we found that smoking cessation resulted in a
return to normal lung function, as measured by V/Q re-
lationships, and decreased inflammation. However, it
has been established that other pathological markers,
such as bronchial-associated lymphoid tissue, remain
after smoking cessation [17]. Likewise, the airspace en-
largement present after 24 weeks of cigarette smoke ex-
posure persisted after smoking cessation, but these
emphysematous lesions caused by cigarette smoke ex-
posure were mild compared to elastase induced airspace
enlargement and likely were not sufficient enough to
contribute to V/Q mismatch. It is possible that the re-
solution of the imaging methodology was unable to de-
tect the mismatch caused by these small, persistent
structural changes; however, if airspace enlargement
were to continue, V/Q mismatch and impaired gas ex-
change would eventually ensue, indicating that smokingcessation in human patients is critical before emphyse-
matous lesions are present; at these early stages of dis-
ease the V/Q mismatch from inflammation could
resolve leaving the gas exchange capabilities of the lung
largely intact.
Work by Suga et al. [11] has begun to explore the V/Q
relationships in COPD patients with advanced emphy-
sema but our results suggest that changes in V/Q may not
be apparent, due to airspace enlargement alone, until this
pathology has progressed substantially as evidenced by the
lack of V/Q mismatching in the presence of mild emphy-
sema in cessation mice. Also of interest, the relationship
between volumes of low x-ray attenuation and V/Q was
not apparent in the comparison of log(V/Q) images to CT
images in PPE-exposed animals. It is possible that regions
neighbouring emphysematous volumes are unable to
function properly, leading to the V/Q mismatch observed.
This warrants further investigation and V/Q SPECT/CT
provides the necessary tools to address this concern. It is
now understood that emphysema progression continues
after smoking cessation [18,19], so development of methods
that can be used clinically to track and understand this
pathology are paramount.
The impact of inflammation on V/Q status is also an
important topic that is not yet well understood. While
LPS caused a greater inflammatory reaction than cigarette
smoke, as observed in both BAL measurements and CT
images, it did not elicit a V/Q disturbance greater than
that of cigarette smoke. It is likely that the distribution of
this inflammation is an important factor, especially as it
pertains to the small airways; constriction of the small air-
ways is undoubtedly heterogeneous and would lead to het-
erogeneous ventilation patterns. As airflow resistance is
inversely proportionate to the radius of the airway to the
Figure 7 Inflammation and airspace enlargement after
16 weeks cessation. A BAL total cells, mononuclear cells, and
neutrophils at 16 weeks post 24 week smoke exposure. ***p < 0.001 by
one-way ANOVA with Tukey post-hoc. B Representative, H&E stained,
whole slice histology from a control (left), cessation (middle), and
continuing smokers at the +16 week time-point. C Average airspace area
distributions by logarithmic bins of airspace, describing whole slice
histology. D Average airspaces per unit area and E average area to
perimeter ratio produced from analysis of whole slice histology.
*p < 0.05, **p < 0.01, ***p < 0.001 by one-way ANOVA with
Tukey post-hoc.
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slight changes in the lumen of small airways could alter
the distribution of ventilation and impact V/Q relation-
ships. Investigations by Gaschler et al. [20] demonstrated
that mucus secretion is not present within the small air-
ways after 8 weeks of cigarette smoke exposure, but there
is thickening of the epithelial layer [21]. V/Q mismatching
is present after 8 weeks smoke exposure in this model
[14], but further investigation into the mechanisms by
which inflammation could affect airflow in this manner is
required. While LPS-derived inflammation caused V/Q
mismatch, likely through airflow obstruction, it is import-
ant to note that cigarette smoke contains additional com-
ponents, such as nitric oxide, that could interfere with
vascular mechanisms, such as hypoxic vasoconstriction,
leading to inadequate matching of perfusion to ventilation
[22,23]. Thus, the V/Q mismatch observed in this model
of cigarette smoke exposure is likely dependent on both
inflammation and an alteration in perfusion, though
greater investigation is still necessary.
In comparison to clinical findings, our data are consistent
with those previously reported by Rodríguez-Roisin et al.
[7] using MIGET where V/Q was shown to be sensitive to
GOLD stage I and that mismatching increased with GOLD
staging severity. The authors also provided evidence that
the V/Q abnormalities seen in GOLD stage I were associ-
ated with smaller airways, alveolar airspaces, and blood ves-
sels. Our data suggests that inflammation could play a large
role in the V/Q mismatching observed in early COPD,
while other pathologies, such as emphysema and small air-
way fibrosis, become a principal cause of V/Q mismatching
in the later stages of COPD. SPECT V/Q has previously
been shown, through work by Petersson et al. [24], to
closely parallel MIGET results such as those described
above but it is important to note that our protocol did not
contain a measurement of total cardiac output. As such,
this preclinical technique approximates overall V/Q distri-
bution. Nevertheless, due to the consistent attributes inher-
ent in an experimental model, as compared to human
subjects, we believe that our V/Q results are representative
of the state of the lungs in the contexts described.
The pulmonary processes of ventilation and perfusion are
both affected by long-term exposure to cigarette smoke.
Cessation of cigarette smoking results in a return of V/Q
assessed lung function to normal, but the pathological con-
sequences of continued exposure eventually lead to struc-
tural damage and functional impairment. It is possible that
these pathologies could be detected early with the aid of
V/Q methods and cessation initiated before major damage
permanently alters pulmonary lung function.
Conclusions
While models of COPD cannot reproduce the disease it-
self in entirety, they allow research to address both the
Figure 8 Impact of 16 weeks cessation on lung function. A Representative axial CT (left) and log(V/Q) (right) images for control (top),
cessation (middle), and continuing cigarette smoke exposed (bottom) animals after +16 weeks. Green represents matched V/Q while colours
progressing towards purple and red represent increasing values of low and high V/Q, respectively. B Log(V/Q) distributions for animals at +16
weeks. C Average mean log(V/Q) values. D Average log(V/Q) standard deviation values. *p < 0.05, **p < 0.01 by one-way ANOVA with
Tukey post-hoc.
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gies therein. We have demonstrated that both inflamma-
tion and emphysematous lesions can contribute to V/Q
mismatching and that cigarette-smoking cessation prior to
large-scale structural changes can reverse the V/Q imbal-
ance. Spatial methodologies utilising V/Q, especially those
coupled to anatomical imaging methods, can provide in-
formation not accessible by other means. The ability to
translate knowledge of lung structure and function gar-
nered in preclinical models to that seen in clinical disease
could provide better diagnosis, treatment, and under-
standing of chronic respiratory diseases such as COPD.
Additional file
Additional file 1: An expanded Materials and Methods section is
available for additional information regarding many of the models
and techniques employed in this study.
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